Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

March 30, 2026

Conditions
End Stage Kidney Disease
Interventions
DIETARY_SUPPLEMENT

Standard Table Salt

Standard Table Salt is administered orally. It is transferred to unmarked saltshakers by non-blinded research coordinators. The unmarked saltshaker is delivered to the participant during dialysis.

DIETARY_SUPPLEMENT

Salt Substitute

"Salt Substitute is available as a crystalized powder. It substitutes potassium chloride for sodium chloride, and thus contains about 50% less sodium than standard table salt.~Salt Substitute is administered orally. It is transferred to unmarked saltshakers by non-blinded research coordinators. The unmarked saltshaker is delivered to the participant during dialysis."

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT05558267 - Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease | Biotech Hunter | Biotech Hunter